Under the deal, Peptris Technologies is licensing PEPR124 (RT001), a preclinical-stage drug, to Revio Therapeutics for ...

The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...

From premature birth to tooth decay, know the ways poor oral health can affect mother and baby’s health during pregnancy.

GameChanger Law Advisors advised Peptris Technologies on its licensing agreement with Revio Therapeutics for PEPR124 (RT001), ...

The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also ...

Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease----Data Presented at the 2025 Muscular ...

Capricor presented preclinical data at the 2024 American Association of Extracellular Vesicles (AAEV) Annual Meeting. The ...

Avoidance is common, but in more severe cases, it can rule our lives. Avoidance is a coping mechanism for anxiety, although ...

Shares of Sarepta Therapeutics have struggled for the past year due to concerns about the commercial potential of its gene ...

While Katie Price insists she hasn't had further work on her gleaming Turkey teeth, a dentist has warned of the risks the ...